News

Back

TheraVet announces the launch of the pivotal European multicentric clinical study of VISCO-VET in canine osteoarthritis

September 10th 2021

BSCB Dev

TheraVet, a pioneering company in the management of osteoarticular diseases in pets, today announces the launch of the pivotal European multicentric clinical study assessing VISCO-VET in canine osteoarthritis.

Read Pdf